Skip to content

Ayurvedic management of UTI in pregnancy

In Vitro and Clinical evaluation of Aamlaki Emblica officinalis and Daruharidra Berberis aristata in combined form in comparison with Tab Cefixime in the Management of Garbhini Mutrakrichra wsr to Urinary Tract Infection in Pregnancy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050954
Enrollment
40
Registered
2023-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O235- Infections of the genital tract inpregnancy Health Condition 2: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

PARUL INSTITUTE OF AYURVED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Lakshanas of Garbhini Mutrakrichra like Sadahamutrata, Sarujamutrata, Muhur-muhurmutrata. Symptoms of Lower UTI in pregnancy like dysuria, burning, frequency, urgency and strangury. Both primi & multigravida in 2nd and 3rd trimester of Pregnancy. Age group in between 18 to 35 years. Laboratory investigations showing pus cells in urine ( >5 pus cells/HPF).

Exclusion criteria

Exclusion criteria: Patients not willing for trial. Patients suffering from medical illness like Poly-cystic kidneys, Hydronephrosis, Impaired renal functions, Malignancy of genito- urinary tract, Immuno-compromised patient. Uncontrolled Hypertension, Gestational Diabetes and Anaemia ( Complications of pregnancy like placental abnormalities. Polyhydramnios Bad obstetric history.

Design outcomes

Primary

MeasureTime frame
Relief from Symptoms of UTI Timepoint: Follow up on DAY 6 AND DAY 12

Secondary

MeasureTime frame
Non Recurrence of symptoms of UTI during pregnancyTimepoint: DAY 12

Countries

India

Contacts

Public ContactDr Manjusha Karkare

Parul Institute Of Ayurved

mrkarkare@gmail.com9422515717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026